GW Pharmaceuticals Profit Margin

The latest profit margin for GWPH is -12.49% as of March 2021. That compares with 8.42% in the prior-year period — down 248.3% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside GW Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, GWPH's profit margin moved from 8.42% to -12.49% — a 248.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GW Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, GWPH currently prints -12.49% for profit margin, while the sector average sits near 15.29%. That is roughly 181.7% below the sector mean. Large gaps often invite a closer look at GW Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively GW Pharmaceuticals converts resources into returns. At -12.49%, GWPH may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 8.42% in the prior-year period — down 248.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GWPH's profit margin (-12.49%), review year-over-year change from 8.42%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.